Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production.

Cancer Immunol Immunother 2011 Mar 14;60(3):381-8. Epub 2010 Dec 14.

Department of Surgery, Immunity and Infection Research Centre, Vancouver Coastal Health Research Institute, University of British Columbia, 950 West 28th Ave, Vancouver, BC V5Z4H4, Canada.

Dendritic cell (DC) vaccines offer a robust platform for the development of cancer vaccines, but their effectiveness is thought to be limited by T regulatory cells (Tregs). Recombinant adenoviruses (RAdV) have been used successfully to engineer tumor antigen expression in DCs, but the impact of virus transduction on susceptibility to suppression by Tregs is unknown. We investigated the functional consequences of exposure to adenovirus on interactions between human monocyte-derived DCs and Tregs. Since the development of Tregs is linked to that of pro-inflammatory Th17 cells, the role of Th17 cells and IL-17-producing Tregs in the context of DC-based immunotherapies was also investigated. We found that Tregs potently suppressed the co-stimulatory capacity of RAdV-transduced DCs, regardless of whether the DCs were maturated by inflammatory cytokines or by exposure to Th1 or Th17 cells. Furthermore, exposure of Tregs to RAdV-exposed DCs increased IL-17 production and suppressive capacity, and correlated with enhanced secretion of IL-1β and IL-6 by DCs. The findings that DCs exposed to RAdV are suppressed by Tregs, promote Treg plasticity, and enhance Treg suppression indicates that strategies to limit Tregs will be required to enhance the efficacy of such DC-based immunotherapies.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0948-4DOI Listing
March 2011
43 Reads

Publication Analysis

Top Keywords

th17 cells
12
tregs
9
dc-based immunotherapies
8
regulatory cells
8
dcs
7
cells
6
potently suppressed
4
tregs potently
4
immunotherapies investigated
4
exposure th1
4
suppressed co-stimulatory
4
investigated tregs
4
co-stimulatory capacity
4
dcs maturated
4
maturated inflammatory
4
inflammatory cytokines
4
dcs dcs
4
radv-transduced dcs
4
capacity radv-transduced
4
context dc-based
4

References

(Supplied by CrossRef)

S Nayak et al.
Gene Ther 2009

R Fontana et al.
Blood 2009

M Nakamura et al.
Oncology 2005

LH Butterfield et al.
J Immunother 2008

H Tsao et al.
Arch Dermatol 2002

TL Whiteside et al.
Expert Opin Biol Ther 2010

W Zou et al.
Nat Rev Immunol 2006

GP Dunn et al.
Immunity 2004

S Sakaguchi et al.
Nat Immunol 2005

DA Vignali et al.
Nat Rev Immunol 2008

Similar Publications